Status:
ACTIVE_NOT_RECRUITING
Assessing Patient Comfort, Anxiety, and Satisfaction During CR Comparing Conventional Drops With ROC
Lead Sponsor:
Superior University
Conditions:
Cycloplegic Paralysis of Accommodation
Eligibility:
All Genders
10-20 years
Phase:
NA
Brief Summary
This study aims to compare the efficacy of conventional cycloplegic agents, such as cyclopentolate, with rapid-onset cycloplegics, like a combination of tropicamide and phenylephrine, in reducing pati...
Detailed Description
The study will involve participants aged 3-16 years, with no significant refractive error or ocular pathologies. Patients will be randomly assigned to receive either cyclopentolate or tropicamide with...
Eligibility Criteria
Inclusion
- Patients aged 10-20years.
- Both Male and Female
- Healthy participants with no abnormalities detected in anterior segment structures or fundus examination using slit-lamp biomicroscopy and a 90-diopter lens.
- No significant refractive error (within the range of ±1 diopter in spherical equivalent).
Exclusion
- History of severe allergic reactions or adverse effects to cycloplegic agents
- Severe anxiety, panic disorders, or other psychological conditions that may interfere with reporting the experience accurately.
- Uncontrolled systemic diseases (e.g., uncontrolled diabetes or cardiovascular conditions) that may impact the response to cycloplegic agents.
- Recent ocular surgery (e.g., LASIK, cataract surgery) or eye trauma affecting refraction accuracy or comfort.
- Presence or history of any intraocular diseases, including glaucoma, uveitis, and retinal disorders.
- Systemic disorders such as hypertension, cardiovascular disease, or respiratory disease.
Key Trial Info
Start Date :
March 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2026
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT06914063
Start Date
March 20 2025
End Date
February 20 2026
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al Shifa trust eye Hospital
Sukkur, Sindh, Pakistan